Cargando…
Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic
BACKGROUND: Seven-day clinical pharmacy services in the acute sector of the National Health Service are limited. There is a paucity of evidential patient benefit. This limits investment and infrastructure, despite United Kingdom wide calls. AIM: To optimise medicines seven-days a week during surge-2...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650667/ https://www.ncbi.nlm.nih.gov/pubmed/36367601 http://dx.doi.org/10.1007/s11096-022-01475-8 |
_version_ | 1784828072902524928 |
---|---|
author | Cheng, C. Walsh, A. Jones, S. Matthews, S. Weerasooriya, D. Fernandes, R. J. McKenzie, C. A. |
author_facet | Cheng, C. Walsh, A. Jones, S. Matthews, S. Weerasooriya, D. Fernandes, R. J. McKenzie, C. A. |
author_sort | Cheng, C. |
collection | PubMed |
description | BACKGROUND: Seven-day clinical pharmacy services in the acute sector of the National Health Service are limited. There is a paucity of evidential patient benefit. This limits investment and infrastructure, despite United Kingdom wide calls. AIM: To optimise medicines seven-days a week during surge-2 of the COVID-19 pandemic through implementation of a seven-day clinical pharmacy service. This paper describes service development, evaluation and sustainability. SETTING: A tertiary-referral teaching hospital, London, United Kingdom. DEVELOPMENT: The seven-day clinical pharmacy service was developed to critical care, acute and general medical patients. Clinical leads developed the service specification and defined priorities, targeting complex patients and transfer of care. Contributing staff were briefed and training materials developed. IMPLEMENTATION: The service was implemented in January 2021 for 11 weeks. Multidisciplinary team communication brought challenges; strategies were employed to overcome these. EVALUATION: A prospective observational study was conducted in intervention wards over two weekends in February 2021. 1584 beds were occupied and 602 patients included. 346 interventions were reported and rated; 85.6% had high or moderate impact; 56.7% were time-critical. The proportion of medicines reconciliation within 24-h of admission was analysed across the hospital between November 2020 and May 2021. During implementation, patients admitted Friday-Sunday were more likely to receive medicines reconciliation within 24-h (RR 1.41 (95% CI 1.34–1.47), p < 0.001). Rostered services were delivered sustainably in terms of shift-fill rate and medicines reconciliation outcome. CONCLUSION: Seven-day clinical pharmacy services benefit patient outcome through early medicines reconciliation and intervention. Investment to permanently embed the service was sustained. |
format | Online Article Text |
id | pubmed-9650667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-96506672022-11-14 Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic Cheng, C. Walsh, A. Jones, S. Matthews, S. Weerasooriya, D. Fernandes, R. J. McKenzie, C. A. Int J Clin Pharm ESCP Best Practice BACKGROUND: Seven-day clinical pharmacy services in the acute sector of the National Health Service are limited. There is a paucity of evidential patient benefit. This limits investment and infrastructure, despite United Kingdom wide calls. AIM: To optimise medicines seven-days a week during surge-2 of the COVID-19 pandemic through implementation of a seven-day clinical pharmacy service. This paper describes service development, evaluation and sustainability. SETTING: A tertiary-referral teaching hospital, London, United Kingdom. DEVELOPMENT: The seven-day clinical pharmacy service was developed to critical care, acute and general medical patients. Clinical leads developed the service specification and defined priorities, targeting complex patients and transfer of care. Contributing staff were briefed and training materials developed. IMPLEMENTATION: The service was implemented in January 2021 for 11 weeks. Multidisciplinary team communication brought challenges; strategies were employed to overcome these. EVALUATION: A prospective observational study was conducted in intervention wards over two weekends in February 2021. 1584 beds were occupied and 602 patients included. 346 interventions were reported and rated; 85.6% had high or moderate impact; 56.7% were time-critical. The proportion of medicines reconciliation within 24-h of admission was analysed across the hospital between November 2020 and May 2021. During implementation, patients admitted Friday-Sunday were more likely to receive medicines reconciliation within 24-h (RR 1.41 (95% CI 1.34–1.47), p < 0.001). Rostered services were delivered sustainably in terms of shift-fill rate and medicines reconciliation outcome. CONCLUSION: Seven-day clinical pharmacy services benefit patient outcome through early medicines reconciliation and intervention. Investment to permanently embed the service was sustained. Springer International Publishing 2022-11-11 2023 /pmc/articles/PMC9650667/ /pubmed/36367601 http://dx.doi.org/10.1007/s11096-022-01475-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | ESCP Best Practice Cheng, C. Walsh, A. Jones, S. Matthews, S. Weerasooriya, D. Fernandes, R. J. McKenzie, C. A. Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic |
title | Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic |
title_full | Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic |
title_fullStr | Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic |
title_full_unstemmed | Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic |
title_short | Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic |
title_sort | development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the covid-19 pandemic |
topic | ESCP Best Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650667/ https://www.ncbi.nlm.nih.gov/pubmed/36367601 http://dx.doi.org/10.1007/s11096-022-01475-8 |
work_keys_str_mv | AT chengc developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic AT walsha developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic AT joness developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic AT matthewss developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic AT weerasooriyad developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic AT fernandesrj developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic AT mckenzieca developmentimplementationandevaluationofasevendayclinicalpharmacyserviceinatertiaryreferralteachinghospitalduringsurge2ofthecovid19pandemic |